The Community Pharmacy England has raised a concern on pricing and availability of Atorvastatin tablets.
CPE is In discussions with the Department of Health and Social Care (DHSC) and have warned about the serious impact this issue is now having on pharmacies.
The issue was highlighted after a number of pharmacy owners have got in touch with CPE about the pricing and availability of Atorvastatin tablets.
The association said: “The DHSC Supply Team has been working closely with manufacturers and wholesalers on this issue.
Thank you to those of you who have taken the time to report the increased prices that you have purchased at.
We will continue to use these reports to highlight just how much of an impact this is having on pharmacies who are desperately trying to get hold of limited stock and having to pay inflated prices for it without any certainty of their final reimbursement prices.”